Murphy Michael R buys $19,019,143 stake in Natera Inc (NTRA)

Natera Inc (NTRA) : Murphy Michael R scooped up 46,591 additional shares in Natera Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 1,729,013 shares of Natera Inc which is valued at $19,019,143.Natera Inc makes up approximately 6.76% of Murphy Michael R’s portfolio.

Other Hedge Funds, Including , Blackrock Group Ltd added NTRA to its portfolio by purchasing 10,526 company shares during the most recent quarter which is valued at $115,786.New York State Common Retirement Fund boosted its stake in NTRA in the latest quarter, The investment management firm added 19,100 additional shares and now holds a total of 27,000 shares of Natera Inc which is valued at $297,000.Blackrock Institutional Trust Company N.a. boosted its stake in NTRA in the latest quarter, The investment management firm added 173,832 additional shares and now holds a total of 356,717 shares of Natera Inc which is valued at $3,923,887. Sg Americas Securities added NTRA to its portfolio by purchasing 11,552 company shares during the most recent quarter which is valued at $149,829.

Natera Inc opened for trading at $9.91 and hit $10.11 on the upside on Monday, eventually ending the session at $10.06, with a gain of 2.34% or 0.23 points. The heightened volatility saw the trading volume jump to 1,52,293 shares. Company has a market cap of $521 M.

On the company’s financial health, Natera Inc reported $-0.46 EPS for the quarter, based on the information available during the earnings call on Aug 4, 2016. Analyst had a consensus estimate of $-0.46. The company had revenue of $52.00 million for the quarter, compared to analysts expectations of $51.91 million. The company’s revenue was up 15.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.40 EPS.

Many Wall Street Analysts have commented on Natera Inc. Company shares were Reiterated by The Benchmark Company on May 23, 2016 to “Buy”, Firm has raised the Price Target to $ 16 from a previous price target of $15 .

Natera Inc. is a diagnostics company. The Company has molecular and bioinformatics technology that it deploys to change genetic diseases across the world. Its molecular assays measure various regions across the genome from samples as small as a single cell. Its statistical algorithms combine these measurements with the available data to detect a range of serious conditions. It is engaged in developing products for various oncology applications. In addition to its direct sales force in the United States the Company has a global network of over 70 laboratory and distribution partners. It has introduced a cloud-based distribution model. It also has launched seven molecular diagnostic tests. The Company launched Panorama which is its non-invasive prenatal test (NIPT). Its products include Pre-implantation Genetic Screening Pre-implantation Genetic Diagnosis Products of Conception Non-Invasive Paternity Testing High Throughput Carrier Screening and Non-Invasive Prenatal Testing.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Natera Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Natera Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.